Texas Pharmaceutical Initiative (TPI) Board Meeting Recap 6.25.25


At its June meeting, the Texas Pharmaceutical Initiative (TPI) Board discussed implementing HB 4638, which extends TPI through 2027 and expands its Board from three to five members. Their revised workplan narrows TPI’s focus to three programs: developing a comprehensive pharmacy benefit for state employee and retiree plans, evaluating the feasibility of a state pharmaceutical distribution system, and exploring in-state drug manufacturing and innovation. The June Board meeting discussed this revised plan as well as the May 2025 Financial Report, two new staff positions, contract updates, and more.

Click here to view TAHP’s full summary of the June 25th meeting.

Become a Member

Membership with TAHP is an invaluable tool for integrating, building relationships, exchanging information and best practices, and promoting your services. You will be well-armed with the most timely and accurate information, strong relationships with key Texas leaders, and access to seasoned policy and regulatory experts.